We are live on ! Find out more
T

TOBAM Portfolio holdings

AUM $384M
1-Year Est. Return 10.32%
This Fund
S&P 500
This Quarter Est. Return
+7.64%
1 Year Est. Return
+10.32%
3 Year Est. Return
+36.67%
5 Year Est. Return
+41.37%
10 Year Est. Return
+233.72%
AUM
$2.5B
AUM Growth
+$144M
Cap. Flow
+$16.9M
Cap. Flow %
0.68%
Top 10 Hldgs %
23.95%
Holding
453
New
26
Increased
85
Reduced
124
Closed
20

Top Buys

1
LLY icon
Eli Lilly
LLY
+$23M
2
NVAX icon
Novavax
NVAX
+$18.4M
3
IQ icon
iQIYI
IQ
+$17.4M
4
CBOE icon
Cboe Global Markets
CBOE
+$17M
5
NFLX icon
Netflix
NFLX
+$16.8M

Top Sells

1
SRPT icon
Sarepta Therapeutics
SRPT
+$27.7M
2
ROKU icon
Roku
ROKU
+$20.6M
3
SPG icon
Simon Property Group
SPG
+$16.5M
4
NIO icon
NIO
NIO
+$15.7M
5
MRNA icon
Moderna
MRNA
+$13.5M

Sector Composition

1 Consumer Staples 21.66%
2 Healthcare 21%
3 Consumer Discretionary 11.38%
4 Communication Services 9.41%
5 Materials 8.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALL icon
226
Allstate
ALL
$64.3B
$130K 0.01%
1,000
– –
PXD
227
DELISTED
Pioneer Natural Resource Co.
PXD
$127K 0.01%
784
– –
IFF icon
228
International Flavors & Fragrances
IFF
$20B
$126K 0.01%
842
– –
ROP icon
229
Roper Technologies
ROP
$36.6B
$126K 0.01%
268
+151
+129% +$66.8K
STZ icon
230
Constellation Brands
STZ
$22.7B
$125K 0.01%
535
– –
PPG icon
231
PPG Industries
PPG
$26.1B
$124K 0.01%
730
– –
TAL icon
232
TAL Education Group
TAL
$5.68B
$124K 0.01%
4,905
-81,996
-94% -$3.66M
ZBH icon
233
Zimmer Biomet
ZBH
$17.6B
$124K 0.01%
795
– –
AZO icon
234
AutoZone
AZO
$49.7B
$122K ﹤0.01%
82
-39
-32% -$56.5K
CMI icon
235
Cummins
CMI
$89.5B
$122K ﹤0.01%
499
– –
ALGN icon
236
Align Technology
ALGN
$12.7B
$121K ﹤0.01%
198
-63
-24% -$37.3K
SBAC icon
237
SBA Communications
SBAC
$19.7B
$121K ﹤0.01%
380
– –
WELL icon
238
Welltower
WELL
$172B
$119K ﹤0.01%
1,426
– –
XRAY icon
239
Dentsply Sirona
XRAY
$2.82B
$119K ﹤0.01%
1,878
-1,597
-46% -$105K
YUM icon
240
Yum! Brands
YUM
$40.8B
$119K ﹤0.01%
1,034
– –
ROK icon
241
Rockwell Automation
ROK
$51.4B
$118K ﹤0.01%
413
– –
BAC icon
242
Bank of America
BAC
$430B
$116K ﹤0.01%
2,816
+1,378
+96% +$56.5K
VNO icon
243
Vornado Realty Trust
VNO
$7.59B
$116K ﹤0.01%
2,484
-33,728
-93% -$1.58M
MCK icon
244
McKesson
MCK
$98.5B
$115K ﹤0.01%
599
– –
KMI icon
245
Kinder Morgan
KMI
$71.9B
$113K ﹤0.01%
6,190
– –
VLO icon
246
Valero Energy
VLO
$91.9B
$113K ﹤0.01%
1,450
– –
PEG icon
247
Public Service Enterprise Group
PEG
$39.2B
$112K ﹤0.01%
1,870
– –
CSGP icon
248
CoStar Group
CSGP
$12.2B
$111K ﹤0.01%
1,340
– –
WMB icon
249
Williams Companies
WMB
$89.7B
$110K ﹤0.01%
4,149
– –
FRC
250
DELISTED
First Republic Bank
FRC
$110K ﹤0.01%
587
– –
8 9
10
11 12

Similar funds

PCM
Pinnbrook Capital Management New York $384M AUM 147.48% 1-Year Est. Return
DFA
Delta Financial Advisors New Orleans, Louisiana $384M AUM 26.86% 1-Year Est. Return
BAMG
Brand Asset Management Group Chesterfield, Missouri $385M AUM 22.41% 1-Year Est. Return
DR
Davis Rea Toronto, Ontario, Canada $384M AUM 11.74% 1-Year Est. Return
GCP
Garda Capital Partners Wayzata, Minnesota $385M AUM 7.25% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return
GA
GSG Advisors Mount Laurel, New Jersey $385M AUM 19.83% 1-Year Est. Return
VI
VectorGlobal IAG Miami, Florida $385M AUM

TOBAM's Q2 2021 Portfolio in Review

As of Q2 2021, TOBAM held 453 positions worth $2.5B, up 6.1% from $2.35B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

TOBAM's Q2 2021 filing shows 26 new, 85 increased, 124 reduced and 20 closed positions. Its largest new stake was GFL Environmental: 313,947 shares worth $10M. The largest sale was Sarepta Therapeutics, an estimated $27.7M.

By sector, the portfolio is most concentrated in Consumer Staples at 22% of assets, down from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • TOBAM's largest Q2 2021 buy was GFL Environmental: 313,947 shares worth $10M.
  • TOBAM added most to Eli Lilly in Q2 2021, an estimated $23M increase.
  • TOBAM's biggest Q2 2021 reduction was Roku, cutting an estimated $20.6M.
  • TOBAM fully exited Sarepta Therapeutics in Q2 2021, selling an estimated $27.7M.
  • TOBAM's ten largest holdings make up 24% of its $2.5B portfolio in Q2 2021.
  • TOBAM opened 26 new positions and closed 20 in Q2 2021.
  • TOBAM's portfolio value rose 6.1% quarter-over-quarter to $2.5B.

Based on TOBAM's 13F filing for Q2 2021, filed 11 Aug 2021.